The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Lijo Chacko is the Chief Executive Officer – Middle East & Africa at Sigachi Industries
ARGX-119 is the sixth molecule developed through our Immunology Innovation Program to show proof-of-concept
Capstan's lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP) that delivers an mRNA encoding an anti-CD19 chimeric antigen receptor (CAR) to CD8-expressing cytotoxic T cells in vivo
Viatel bioresorbable polymers are increasingly used in dental and orthopedic implants
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
BioNTech and Bristol Myers Squibb will jointly execute a broad clinical development program to evaluate and advance BNT327 across numerous solid tumor types
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants
Subscribe To Our Newsletter & Stay Updated
